|Bid||0.2894 x N/A|
|Ask||0.3174 x N/A|
|Day's Range||0.2923 - 0.3098|
|52 Week Range||0.2906 - 2.6600|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 10, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Arcadia Biosciences ( NASDAQ:RKDA ) Third Quarter 2022 Results Key Financial Results Revenue: US$1.88m (down 21% from...
Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of 36.84% and 43.77%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a producer and marketer of innovative, plant-based health and wellness products, today released its financial and business results for the third quarter of 2022.